20 Participants Needed

Hearing Aid Signal Processing for Alzheimer's Disease

Recruiting at 1 trial location
KM
Overseen ByKendra Marks, Au.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Northwestern University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This current translational project, funded by NIH, aims to better understand the impact of various signal modification strategies for older adults with Alzheimer's dementia and its potential precursor, known as amnestic mild cognitive impairment. The investigators hypothesize that adults with Alzheimer's dementia represent an extreme case of restricted cognitive ability, such that very low working memory capacity and overall reduced cognitive capacity will limit benefit from advanced signal processing. Thus, the investigators hypothesize that adults with Alzheimer's dementia will receive greater benefit from acoustically simple, high-fidelity hearing aid processing that minimally alters the acoustic signal.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment High level of signal manipulation, Advanced signal processing, Complex signal modification, Low level of signal manipulation, Basic Signal Processing, Minimal Signal Alteration, High-Fidelity Hearing Aid Processing for Alzheimer's Disease?

Research shows that digital hearing aids, which use advanced signal processing, can improve speech perception in noisy environments for people with hearing loss. This suggests that similar signal processing techniques might help Alzheimer's patients with hearing difficulties, potentially aiding in better communication and cognitive engagement.12345

Is hearing aid signal processing safe for humans?

Hearing aid signal processing, including advanced techniques like noise reduction and frequency lowering, is generally considered safe for humans. However, individual responses can vary based on factors like age, degree of hearing loss, and cognitive abilities.678910

How does the treatment 'Hearing Aid Signal Processing for Alzheimer's Disease' differ from other treatments for Alzheimer's?

This treatment is unique because it uses advanced digital signal processing in hearing aids to improve speech understanding for Alzheimer's patients, potentially addressing both hearing loss and cognitive challenges by enhancing sound clarity and reducing background noise.1261112

Research Team

PS

Pam Souza, PhD

Principal Investigator

Northwestern University

Eligibility Criteria

This trial is for older adults with Alzheimer's dementia or its precursor, amnestic mild cognitive impairment. Participants must speak English, have normal vision or corrected-to-normal vision, sensorineural hearing loss within specific parameters, and a certain level of cognitive function. They should live at home and be able to consent to the study.

Inclusion Criteria

Minimum Grade 10 education
You have slight or mild problems with memory, thinking, and daily activities.
Speak English as their primary language
See 5 more

Exclusion Criteria

You have had a serious mental illness like schizophrenia or severe untreated depression.
You are also participating in other studies focused on improving hearing, language, or communication.
You currently use a hearing aid for at least 4 hours a day on most days in the past year.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants will use two different hearing aid signal processing strategies, each for 3-5 weeks

6-10 weeks
Multiple visits for fitting and assessment

Follow-up

Participants are monitored for changes in speech intelligibility and conversation analysis after treatment

4 weeks

Treatment Details

Interventions

  • High level of signal manipulation
  • Low level of signal manipulation
Trial OverviewThe study tests two types of signal manipulation in hearing aids: one with high levels of alteration and another with low levels. It aims to determine which strategy benefits those with Alzheimer's dementia more by providing clearer sound without too much processing.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Hearing Aid Fitting Order BExperimental Treatment2 Interventions
Participants wear hearing aids with a low level of signal manipulation, followed by a high level of signal manipulation
Group II: Hearing Aid Fitting Order AExperimental Treatment2 Interventions
Participants wear hearing aids with a high level of signal manipulation, followed by a low level of signal manipulation

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

Findings from Research

A meta-analysis of six studies involving 171 Alzheimer's Disease (AD) patients and 222 age-matched controls found that individuals with AD have significantly poorer hearing, with an average increase of 2.3 dB HL at lower frequencies (0.5-2 kHz) and 4.5 dB HL at higher frequencies (0.5-4 kHz).
This study highlights the importance of quantifying hearing loss in AD patients, suggesting that hearing impairment may serve as a potential biomarker for earlier diagnosis and treatment strategies for Alzheimer's Disease.
Pure Tone Audiometry and Hearing Loss in Alzheimer's Disease: A Meta-Analysis.Kwok, SS., Nguyen, XT., Wu, DD., et al.[2023]
Digital hearing aids (HAs) offer advanced features like adaptive filtration and signal reconstruction, which significantly improve speech perception in noisy environments for individuals with hearing loss.
These digital HAs are designed using effective signal processors that enhance their performance and reliability, making them a superior option compared to traditional analog hearing aids.
[Ways of using digital signal processing for expanding the potentials of hearing aids].Babkina, LN., Molchanov, AP.[2006]
Hearing aids are essential for patients with noncorrectable hearing loss, aiming to amplify speech for better understanding, enhance environmental sound awareness, and support language development in children with early hearing loss.
The article reviews the current technology of hearing aids, highlighting their benefits and limitations, while also addressing important medical considerations for fitting these devices in patients' ears.
Hearing aid evaluation and fitting.Popelka, GR., Gates, GA.[2012]

References

Pure Tone Audiometry and Hearing Loss in Alzheimer's Disease: A Meta-Analysis. [2023]
2.Russia (Federation)pubmed.ncbi.nlm.nih.gov
[Ways of using digital signal processing for expanding the potentials of hearing aids]. [2006]
Hearing aid evaluation and fitting. [2012]
New perspectives on assessing amplification effects. [2019]
[Evaluation of hearing improvement due to hearing aids]. [2007]
Cognition and hearing aids. [2009]
Functionality of hearing aids: state-of-the-art and future model-based solutions. [2019]
Listener Performance with a Novel Hearing Aid Frequency Lowering Technique. [2022]
Understanding Variability in Individual Response to Hearing Aid Signal Processing in Wearable Hearing Aids. [2023]
[Modern hearing-aids at the cutting edge of microelectronics. Increased possibilities for individual customization]. [2012]
[Speech comprehension by patients with Alzheimer disease. Possibilities for improvement]. [2012]
[Hearing impairment in senile dementia of Alzheimer's type]. [2006]